(Kang Gu-Son) - Stanford University Department of Medicine Division of Cardiovascular Medicine
(Kim Ju-Yong Brian) - Stanford University Department of Medicine Division of Cardiovascular Medicine
Abstract
Since the first-in-man transcatheter delivery of an aortic valve prosthesis in 2002, the landscape of aortic stenosis therapeutics has shifted dramatically. While initially restricted to non-surgical cases, progressive advances in transcatheter aortic valve replacement and our understanding of its safety and efficacy have expanded its use in intermediate and possibly low surgical risk patients. In this review, we explore the past, present, and future of transcatheter aortic valve replacement.
Å°¿öµå
Transcatheter aortic valve replacement, Indications, Aortic valve stenosis
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
This review explored the past, present, and future of transcatheter aortic valve replacement; Echocardiographic and computed tomography-guided measurements have also proved useful in predicting procedural outcomes, such as acute mitral regurgitation and aortic regurgitation.